Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NCT ID: NCT03511534
Last Updated: 2025-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
200 participants
INTERVENTIONAL
2017-06-23
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stepped Care for Treating Obsessive-Compulsive Disorder
NCT00316355
Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
NCT00045903
Treatment of Obsessive-Compulsive Disorder
NCT00000373
Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders
NCT03182075
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)
NCT03767491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal is to compare two forms of current standard treatments, psychotherapy vs pharmacotherapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psychotherapy
Participants will receive evidenced based psychotherapy by a trained psychologist
Psychotherapy
Evidenced based psychotherapy by a trained psychologist
Pharmacotherapy
Participants will receive pharmacotherapy by a psychiatrist
Pharmacotherapy
Pharmacotherapy by a psychiatrist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychotherapy
Evidenced based psychotherapy by a trained psychologist
Pharmacotherapy
Pharmacotherapy by a psychiatrist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Capacity to consent (e.g. as determined by assessing the patient's understanding of the risks, benefits, and procedures of the study)
3. Completed an active study protocol at the Rodriguez Lab at Stanford University
Exclusion Criteria
2. Active suicidality
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carolyn Rodriguez
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolyn Rodriguez, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor, Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
41165
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.